March, 2025

article thumbnail

Opinion: Herding cats: It’s past time to include pets in disease surveillance

STAT

As veterinarians, flu scientists, and biosecurity experts, we have watched with growing concern the rise in H5N1 avian influenza in cats. Since 2022, more than 100 domesticated cats in the United States have had confirmed infections — some house pets, some barn cats, some feral — with high mortality, although mortality data remain undocumented on federal sites.

362
362
article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands. The following trends not only shaped the sector then but also set the stage for the future of pharma manufacturing, both in India and globally.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Which Social Media Analytics Matter Most in Pharma Marketing

Pharma Marketing Network

Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.

HIPAA 52
article thumbnail

Conducting a Biopharmaceutical Freedom-to-Operate (FTO) Analysis: Strategies for Efficient and Robust Results

Drug Patent Watch

Avoiding Patent Pitfalls in Biopharmaceutical Development: A Freedom to Operate Analysis As a biopharmaceutical professional, you know how crucial it is to navigate the complex landscape of patents and intellectual property. One of the most critical steps in this process is conducting a freedom to operate (FTO) analysis. But what does this entail, and how can you ensure efficient and robust results?

52
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Pharmacists in general practice improve prescribing quality, study finds

The Pharmacist

The adoption of pharmacists in general practice has resulted in improvements in prescribing quality, according to a recent study. Theresearch, by the University of Manchester, looked at the differences in prescribing indicators in general practices with and without pharmacists between September 2015 and December 2019. During this period, the proportion of practices employing a pharmacist […] The post Pharmacists in general practice improve prescribing quality, study finds appeared first on

71
article thumbnail

Pharma USA 2025: Where Industry Leaders Shaped the Future

Pharma Leaders

Pharma USA 2025 proved to be a pivotal event for navigating the complexities of the pharmaceutical industry. Held at the Pennsylvania Convention Center in Philadelphia on March 18th and 19th, the event addressed the ever-evolving healthcare landscape. The conference gathered a diverse group of professionals from commercial, marketing, medical affairs, real-world evidence, market access, and patient engagement sectors.

More Trending

article thumbnail

Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and innovation

Express Pharma

The Indian pharmaceutical industry is evolving rapidly, leading to the emergence of new leadership roles that address the sector’s dynamic global challenges and opportunities. As the sector adapts to technological advancements, regulatory requirements, and increasing competition, several leadership role trends are emerging. These roles are designed to strengthen the companies’ operational efficiency, expand their market presence, and foster innovation.

article thumbnail

How Has Social Media Advertising Changed in Pharma

Pharma Marketing Network

Introduction Social media advertising has undergone a major transformation in the pharmaceutical industry over the past decade. What once was a cautious, slow-moving experiment has now become a vital component of modern pharma marketing strategies. The increasing integration of platforms like LinkedIn, X (formerly Twitter), YouTube, and even TikTok has dramatically shifted how pharma brands engage with healthcare professionals (HCPs), patients, and caregivers.

HIPAA 52
article thumbnail

What Could Changes in Tariff Policies Mean for Patients?

Putting Patients First Blog

What Could Changes in Tariff Policies Mean for Patients? March 31, 2025 By: Randall Rutta, Chief Executive Officer The Administration has announced its plan to raise tariffs on many materials and products from foreign countries. While what materials and products will be subject to tariffs is evolving, these policies may have detrimental effects for patients seeking care.

52
article thumbnail

The Comprehensive Science and Art of Pharmaceutical Drug Naming

Drug Patent Watch

The Secret Language of Medicines: Uncovering the Science Behind Pharmaceutical Drug Names As professionals in the healthcare and pharmaceutical industries, we've all seen them - the long, complex names of medications that seem to defy pronunciation. But have you ever stopped to think about the process behind creating these names? It's a fascinating world of science and art that's crucial to ensuring patient safety and efficacy.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

NHS England to be scrapped with funding 'reinvested into frontline services'

The Pharmacist

NHS England (NHSE) will be scrapped and brought back into the Department of Health and Social Care (DHSC) 'to put an end to the duplication resulting from two organisations doing the same job', the government has said today. Prime Minister Sir Kier Starmer set out major reforms today, which will include the dissolution of NHSE […] The post NHS England to be scrapped with funding 'reinvested into frontline services' appeared first on The Pharmacist.

119
119
article thumbnail

Down to their heart cells, women and men have cardiovascular differences that matter

STAT

Heart disease has long been the leading killer of adults, but beyond that stark fact, men and women diverge. From differences at the cellular level of the heart to circulatory structure to symptoms of distress and treatment, researchers are finding new manifestations of gender differences in cardiovascular disease.

338
338
article thumbnail

Biocon Biologics announces positive results from Phase 3 Study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis

Express Pharma

Biocon Biologics announced the successful results of a pivotal Phase 3, randomised, double-blind, parallel group, multicenter study comparing Yesintek (Biocon Biologics biosimilar to Ustekinumab, called YESINTEK) with reference product Stelara (Ustekinumab) in adult patients with moderate to severe chronic plaque psoriasis (PsO). The data are being presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida.

article thumbnail

Audience Engagement Strategies for Pharma Marketing: Boost HCP and Patient Interaction

Pharma Marketing Network

Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

FDA Approves Fresenius’s Denosumab Biosimilars

Big Molecule Watch

On March 26, 2025, the FDA approved Fresenius Kabis denosumab biosimilars, CONEXXENCE (denosumab-bnht) and BOMYNTRA (denosumab-bnht), referencing Amgens PROLIA and XGEVA, respectively. These approvals make Fresenius the fourth company to receive FDA approval for a pair of denosumab biosimilars, joining Celltrion , Samsung , and Sandoz. Denosumab is a RANK ligand (RANKL) inhibitor that is used to treat bone loss.

article thumbnail

The Issue with Reissue: PTE Edition

FDA Law Blog: Biosimilars

By Sara W. Koblitz Integral to the careful balance Congress struck when passing the Hatch-Waxman Amendments, the patent term extension (PTE) is intended to restore patent life that was consumed during regulatory review of an FDA-regulated product. Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension.

article thumbnail

Pharmacy First IT funding 'not well spent', says pharmacist MP

The Pharmacist

Money to develop IT systems to support the roll-out of Pharmacy First was 'not well spent', pharmacist and MP Sadik Al-Hassan has suggested. The Labour MP for North Somerset was speaking at a roundtable focusing on community pharmacy technology in parliament yesterday when he was asked by The Pharmacist for his views on the IT […] The post Pharmacy First IT funding 'not well spent', says pharmacist MP appeared first on The Pharmacist.

article thumbnail

Opinion: ‘Post-vaccination syndrome’: a dubious diagnosis that could do harm

STAT

Recently, the notorious conspiracy theory peddler Alex Jones shared an “Infowars” video on X lambasting the “horrific side effects” of Covid vaccines: “Yale scientists link COVID vaccines to alarming new syndrome causing distinct biological changes to the body,” his post read. News of the new study spread like wildfire throughout right-wing anti-vaccine circles, amplified by the likes of Alex Berenson , Elon Musk , and Joe Rogan , who touted the study as

Vaccines 362
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

USC-licensed startup NeOnc Technologies gets NASDAQ listing

Express Pharma

A USC-licensed startup, NeOnc Technologies, that developed an intranasal drug delivery system for brain tumors has got listed for the first time on Nasdaq. NeOnc has also announced a strategic partnership with CBCC Global Research, a CRO, to expand clinical trials across 30 FDA-compliant sites in India, facilitating the advancement of its neuro-oncology treatment.

article thumbnail

Why Healthcare is Seeing an Increase in 2025 Ad Budgeting

Pharma Marketing Network

Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.

article thumbnail

Sustainable method converting waste into pharmaceuticals developed

European Pharmaceutical Review

A team of researchers in Japan have developed a novel artificial photosynthesis method that transforms waste organic compounds into valuable pharmaceuticals and energy using sunlight and water. The approach, known as artificial photosynthesis directed toward organic synthesis (APOS), represents a major step forward in sustainable chemical manufacturing.

article thumbnail

Strategies for effective biosimilar regulatory agency interactions

Drug Patent Watch

Navigating the Complex World of Biosimilar Regulatory Agency Interactions As a biosimilar developer, you know that getting your product to market can be a long and arduous process. One of the most critical components of this journey is interacting with regulatory agencies. But how can you ensure that these interactions are effective and set your product up for success?

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

BREAKING: Community pharmacies get £3bn deal for 2025/26

The Pharmacist

Community Pharmacy England has agreed a 3.073 billion Community Pharmacy Contractual Framework, in a new deal for the sector for 2025/26. A further 215 million will be available for contractors to earn through Pharmacy First, blood pressure and contraception services, while a national emergency hormonal contraception service has been commissioned. The medicines margin for 2025/26 […] The post BREAKING: Community pharmacies get 3bn deal for 2025/26 appeared first on The Pharmacist.

article thumbnail

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT

In the world of nutrition research, dairy is neither hero nor villain. It contains important nutrients like protein and calcium. Yet full-fat dairy also contains relatively high levels of saturated fat, which has been linked to increased levels of harmful LDL cholesterol and greater risk of stroke and heart disease. These complexities mean many health providers aim for nuance in how they talk about dairy, avoiding the full-throated endorsements they might give to leafy greens or legumes while di

article thumbnail

EMA reiterates positive recommendation for Eisai-Biogen’s Alzheimer’s drug

Express Pharma

The European Union’s medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen’s Alzheimer’s drug, Leqembi, after concluding a safety review. The European Medicines Agency (EMA) in late January said the European Commission had requested a review of additional safety information for the drug, following its November approval to treat some patients with early Alzheimer’s disease.

66
article thumbnail

Pharma Ad Retargeting Basics

Pharma Marketing Network

Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. Ad retargeting has become a powerful tool for pharma marketers, enabling brands to re-engage potential customers who have shown interest but have not yet converted. But how does ad retargeting work in pharma marketing, and what strategies yield the best results?

HIPAA 52
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Psilocybin therapy demonstrates sustained clinical benefit in treatment-resistant depression

European Pharmaceutical Review

New results from a trial investigating a synthetic form of psilocybin, administered with psychological support, showed that it extended the time participants with treatment-resistant depression (TRD) were free from depressive symptoms. A single 25mg dose of COMP360 psilocybin had benefit over smaller 1mg and 10mg doses in the 52-week COMP004 follow-up study to the Phase IIb (COMP001 and COMP003) trials.

98
article thumbnail

The future of biosimilar insulin products in diabetes care

Drug Patent Watch

The Future of Diabetes Care: How Biosimilar Insulin Products Are Revolutionizing Treatment As we continue to navigate the ever-evolving landscape of diabetes care, one thing is clear: innovation is key. And when it comes to insulin therapy, a game-changing trend is emerging: biosimilar insulin products. For those who may be unfamiliar, biosimilars are highly similar versions of existing biologic medications, including insulin.

article thumbnail

The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments

Drug Channels

Threes still company in the world of pharmacy benefit managers. For 2024, nearly 80% of all equivalent prescription claims were processed by three familiar companies: the CVS Caremark business of CVS Health, the Express Scripts business of Cigna, and the Optum Rx business of UnitedHealth Group. The names havent changed, but shifting relationships and contract shakeups have altered the plot, with Express Scripts stepping into a new lead role.

98
article thumbnail

Opinion: Former HHS Secretary Donna Shalala on the agency’s ‘silly new bureaucracy’

STAT

When I was secretary of the Department of Health and Human Services under President Bill Clinton, an agency head came to me with a dramatic reorganization plan. I advised him that unless it was data- and outcome-driven, he was wasting his time. Just as important, the reorganization would unsettle and confuse his new colleagues. As a result, his legacy would be a new structure rather than improving people’s lives.

342
342
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.